Literature DB >> 21057861

Novel STAT1 alleles in a patient with impaired resistance to mycobacteria.

Ines Ackerl Kristensen1, Jens Erik Veirum, Bjarne Kuno Møller, Mette Christiansen.   

Abstract

Partial defects in interferon (IFN)-γ signaling lead to susceptibility to infections with nontuberculous mycobacteria. The receptors for IFN-α and IFN-γ activate components of the Janus kinase-signal transducer and activator of transcription (STAT) signaling pathway. Some defects in STAT1 mainly affect IFN-γ signaling, thus resulting in mendelian susceptibility to mycobacterial disease (MSMD). MSMD is a severe disease but patients show a favorable response to anti-mycobacterial chemotherapy. Other defects in STAT1 affect both IFN-α and IFN-γ signaling resulting in mycobacterial and lethal viral disease. We report here a patient with two novel STAT1 alleles, which in combination results in a recessive trait with partial STAT1 deficiency and mycobacterial disease. Cells from the patient did respond to mycobacterial antigen, but both the expression of STAT1 and phosphorylation of STAT1 in response to IFN-γ treatment were reduced. This is the first report of a mutation in the N-terminal part of STAT1 involved in causing mycobacterial disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057861     DOI: 10.1007/s10875-010-9480-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  18 in total

Review 1.  Stats: multifaceted regulators of transcription.

Authors:  Melissa M Brierley; Eleanor N Fish
Journal:  J Interferon Cytokine Res       Date:  2005-12       Impact factor: 2.607

2.  Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain.

Authors:  X Xu; Y L Sun; T Hoey
Journal:  Science       Date:  1996-08-09       Impact factor: 47.728

3.  Structure of the amino-terminal protein interaction domain of STAT-4.

Authors:  U Vinkemeier; I Moarefi; J E Darnell; J Kuriyan
Journal:  Science       Date:  1998-02-13       Impact factor: 47.728

4.  Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements.

Authors:  F Hulstaert; I Hannet; V Deneys; V Munhyeshuli; T Reichert; M De Bruyere; K Strauss
Journal:  Clin Immunol Immunopathol       Date:  1994-02

5.  Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.

Authors:  Stéphanie Dupuis; Emmanuelle Jouanguy; Sami Al-Hajjar; Claire Fieschi; Ibrahim Zaid Al-Mohsen; Suliman Al-Jumaah; Kun Yang; Ariane Chapgier; Céline Eidenschenk; Pierre Eid; Abdulaziz Al Ghonaium; Haysam Tufenkeji; Husn Frayha; Suleiman Al-Gazlan; Hassan Al-Rayes; Robert D Schreiber; Ion Gresser; Jean-Laurent Casanova
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

6.  Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo.

Authors:  Ariane Chapgier; Robert F Wynn; Emmanuelle Jouanguy; Orchidée Filipe-Santos; Shenying Zhang; Jacqueline Feinberg; Kay Hawkins; Jean-Laurent Casanova; Peter D Arkwright
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

Review 7.  The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases.

Authors:  Saleh Al-Muhsen; Jean-Laurent Casanova
Journal:  J Allergy Clin Immunol       Date:  2008-12       Impact factor: 10.793

8.  A partial form of recessive STAT1 deficiency in humans.

Authors:  Ariane Chapgier; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Emmanuelle Jouanguy; Diana Averbuch; Jacqueline Feinberg; Shen-Ying Zhang; Jacinta Bustamante; Guillaume Vogt; Julien Lejeune; Eleonore Mayola; Ludovic de Beaucoudrey; Laurent Abel; Dan Engelhard; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

Review 9.  Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling.

Authors:  M H Haverkamp; J T van Dissel; S M Holland
Journal:  Microbes Infect       Date:  2006-01-19       Impact factor: 2.700

10.  X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.

Authors:  Orchidée Filipe-Santos; Jacinta Bustamante; Margje H Haverkamp; Emilie Vinolo; Cheng-Lung Ku; Anne Puel; David M Frucht; Karin Christel; Horst von Bernuth; Emmanuelle Jouanguy; Jacqueline Feinberg; Anne Durandy; Brigitte Senechal; Ariane Chapgier; Guillaume Vogt; Ludovic de Beaucoudrey; Claire Fieschi; Capucine Picard; Meriem Garfa; Jalel Chemli; Mohamed Bejaoui; Maria N Tsolia; Necil Kutukculer; Alessandro Plebani; Luigi Notarangelo; Christine Bodemer; Frédéric Geissmann; Alain Israël; Michel Véron; Maike Knackstedt; Ridha Barbouche; Laurent Abel; Klaus Magdorf; Dominique Gendrel; Fabrice Agou; Steven M Holland; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  31 in total

1.  A novel STAT1 mutation associated with disseminated mycobacterial disease.

Authors:  Elizabeth P Sampaio; Hannelore I Bax; Amy P Hsu; Ervand Kristosturyan; Joseph Pechacek; Prabha Chandrasekaran; Michelle L Paulson; Dalton L Dias; Christine Spalding; Gulbu Uzel; Li Ding; Elizabeth McFarland; Steven M Holland
Journal:  J Clin Immunol       Date:  2012-02-29       Impact factor: 8.317

Review 2.  Inborn errors of anti-viral interferon immunity in humans.

Authors:  Vanessa Sancho-Shimizu; Rebeca Perez de Diego; Emmanuelle Jouanguy; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

3.  Severe growth deficiency is associated with STAT5b mutations that disrupt protein folding and activity.

Authors:  Benjamin Varco-Merth; Eva Feigerlová; Ujwal Shinde; Ron G Rosenfeld; Vivian Hwa; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2012-11-16

4.  Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.

Authors:  Reiko Kagawa; Ryoji Fujiki; Miyuki Tsumura; Sonoko Sakata; Shiho Nishimura; Yuval Itan; Xiao-Fei Kong; Zenichiro Kato; Hidenori Ohnishi; Osamu Hirata; Satoshi Saito; Maiko Ikeda; Jamila El Baghdadi; Aziz Bousfiha; Kaori Fujiwara; Matias Oleastro; Judith Yancoski; Laura Perez; Silvia Danielian; Fatima Ailal; Hidetoshi Takada; Toshiro Hara; Anne Puel; Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jean-Laurent Casanova; Osamu Ohara; Satoshi Okada; Masao Kobayashi
Journal:  J Allergy Clin Immunol       Date:  2016-12-20       Impact factor: 10.793

Review 5.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

Review 6.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

Review 7.  Advancing host-directed therapy for tuberculosis.

Authors:  Robert S Wallis; Richard Hafner
Journal:  Nat Rev Immunol       Date:  2015-03-13       Impact factor: 53.106

8.  Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis.

Authors:  Osamu Hirata; Satoshi Okada; Miyuki Tsumura; Reiko Kagawa; Mizuka Miki; Hiroshi Kawaguchi; Kazuhiro Nakamura; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Yoshihiro Takihara; Masao Kobayashi
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

Review 9.  A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.

Authors:  Un-In Wu; Steven M Holland
Journal:  Semin Immunopathol       Date:  2016-01-05       Impact factor: 9.623

Review 10.  Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Authors:  Satoshi Okada; Takaki Asano; Kunihiko Moriya; Stephanie Boisson-Dupuis; Masao Kobayashi; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2020-08-27       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.